Meet your study design needs with confidence.
Determining what evidence is needed and the most efficient ways to generate it is key to designing studies that meet regulatory and payer expectations. Navigate the path to regulatory acceptance with:
Regulatory knowledge
IQVIA offers a history of EMA-accepted Drug Utilization Studies (DUS) in multiple therapy areas and geographies and extensive experience working with the FDA, ENCePP, EUnetHTA , MHRA and are active partners and participants with OMOP, ENCePP, EUnetHTA, IMI, the Department of Health and Human Services and others.
Innovative ways to generate evidence
Access a wide spectrum of data and sourcing approaches from existing secondary data, primary data, registry collaborations, and patient reported outcomes.
Accelerated patient recruitment
Connecting with existing real world data sources helps identify the right patients and facilitate recruitment.